Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins

References

• Adams MJ, Lefkowitz EJ, King AMQ, et al. (2017). Changes to taxonomy and the international code of virus classification and nomenclature ratified by the international committee on taxonomy of viruses. Arch Virol, 162, 2505–2538. doi:10.1007/s00705-017-3383-4.
   PubMed Web of Science ®Google Scholar
• Bai XF, Wang YZ, Xu X, et al. (2016). Commercial vaccines provide limited protection to NADC30-like PRRSV infection. Vaccine, 34, 5540–5545. doi:10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar
• Batista-Duharte A, Lindblad EB, Oviedo-Orta E. (2011). Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett, 203, 97–105. doi:10.1016/j.toxlet.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Charerntantanakul W. (2012). Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects. World J Virol, 1, 23–30. doi:10.5501/wjv.v1.i1.23.
   PubMedGoogle Scholar
• Charerntantanakul W, Platt R, Johnson W, et al. (2006). Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol, 109, 99–115. doi:10.1016/j.vetimm.2005.08.029.
   PubMed Web of Science ®Google Scholar
• Chen LQ, Zhang J, Sun HX. (2015). Immunological adjuvant effect of the peptide fraction from the larvae of Musca domestica. BMC Complemen Altern Med, 15, 427–436. doi:10.1186/s12906-015-0951-6.
   PubMed Web of Science ®Google Scholar
• Cher DJ, Mosmann TR. (1987). Two types of murine helper T-cell clones. II. Delayed-type hypersensitivity is mediated by Th1 clones. J Immunol, 138, 3688–3694.
   PubMed Web of Science ®Google Scholar
• Coffman RL, Seymour BWP, Lebman DA, et al. (1998). The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev, 102, 5–28. doi:10.1111/j.1600-065X.1988.tb00739.x.
   Google Scholar
• Correas I, Osorio FA, Steffen D, et al. (2017). Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection. Vaccine, 35, 782–788. doi:10.1016/j.vaccine.2016.12.040.
   PubMed Web of Science ®Google Scholar
• De Carvalho PG, De Oliveira Rodrigues R, Ribeiro Da Silva SF, et al. (2016). CD38+CD8+ and CD38+CD4+ T cells and IFN gamma (+874) polymorphism are associated with a poor virological outcome. Immunol Invest, 45, 312–327. doi:10.3109/08820139.2016.1157603.
   PubMed Web of Science ®Google Scholar
• Doherty PC, Riberdy JM, Belz GT. (2000). Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. Philos Trans R Soc Lond B Biol Sci, 355, 1093–1101. doi:10.1098/rstb.2000.0647.
   PubMed Web of Science ®Google Scholar
• Doherty PC, Topham DJ, Tripp RA, et al. (1997). Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev, 159, 105–117. doi:10.1111/j.1600-065X.1997.tb01010.x.
   PubMed Web of Science ®Google Scholar
• Dong JG, Yu LY, Wang PP, et al. (2018). A new recombined porcine reproductive and respiratory syndrome virus virulent strain in China. J Vet Sci, 19, 89–98. doi:10.4142/jvs.2018.19.1.89.
   PubMed Web of Science ®Google Scholar
• Du J, Chen XF, Wang CY, Sun HX. (2018). Pathway analysis of global gene expression change in dendritic cells induced by the polysaccharide from the roots of Actinidia eriantha. J Ethnopharmacol, 214, 141–152. doi:10.1016/j.jep.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Ferrari L, Canelli E, De Angelis E, et al. (2018). A highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (PRRSV-1) strongly modulates cellular innate and adaptive immune subsets upon experimental infection. Vet Microbiol, 216, 85–92. doi:10.1016/j.vetmic.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Fontanella E, Ma Z, Zhang Y, et al. (2016). An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs. Vaccine, 35, 125–131. doi:10.1016/j.vaccine.2016.11.020.
   PubMed Web of Science ®Google Scholar
• Foss DL, Zilliox MJ, Meier W, et al. (2002). Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immunol, 15, 557–566. doi:10.1089/088282402320914502.
   PubMed Web of Science ®Google Scholar
• Fuertes LL, Doménech N, Alvarez B, et al. (1999). Analysis of cellular immune response in pigs recovered from porcine respiratory and reproductive syndrome infection. Virus Res, 64, 33–42. doi:10.1016/S0168-1702(99)00073-8.
   PubMed Web of Science ®Google Scholar
• Geldhof MF, Van Breedam W, De Jong E, et al. (2013). Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines. Vet Microbiol, 167, 260–271. doi:10.1016/j.vetmic.2013.08.017.
   PubMed Web of Science ®Google Scholar
• Guo ZH, Chen XX, Li R, et al. (2018). The prevalent status and genetic diversity of porcine reproductive and respiratory syndrome virus in China: a molecular epidemiological perspective. Virol J, 15, 2. doi:10.1186/s12985-017-0910-6.
   PubMed Web of Science ®Google Scholar
• Habjanec L, Halassy B, Tomašić J. (2008). Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. Int Immunopharmacol, 8, 717–724. doi:10.1016/j.intimp.2008.01.017.
   PubMed Web of Science ®Google Scholar
• Han LF, Pan GX, Wang YF, et al. (2011). Rapid profiling and identification of triterpenoid saponins in crude extracts from Albizia julibrissin Durazz. by ultra high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. J Pharm Biomed Anal, 55, 996–1009. doi:10.1016/j.jpba.2011.04.002.
   PubMed Web of Science ®Google Scholar
• Heegaard PMH, Dedieu L, Johnson N, et al. (2011). Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch Virol, 156, 183–202. doi:10.1007/s00705-010-0863-1.
   PubMed Web of Science ®Google Scholar
• Holtkamp DJ, Kliebenstein JB, Neumann EJ, et al. (2013). Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Heal Prod, 21, 72–78.
   Web of Science ®Google Scholar
• Hu J, Zhang C. (2014). Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine. Transbound Emerg Dis, 61, 109–120. doi:10.1111/tbed.12016.
   PubMed Web of Science ®Google Scholar
• Jeong J, Kang I, Kim S, et al. (2018). A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge. Transbound Emerg Dis, doi:10.1111/tbed.12862.
   Web of Science ®Google Scholar
• Kim T, Park C, Choi K, et al. (2015). Comparison of two commercial type 1 porcine reproductive and respiratorysyndrome virus (PRRSV) modified live vaccines against heterologous type 1 and type 2 PRRSV challenge in growing pigs. Clin Vaccine Immunol, 22, 631–640. doi:10.1128/CVI.00001-15.
   PubMed Web of Science ®Google Scholar
• Ko JH, Nguyen PL, Ahn JY, et al. (2015). The global research trend of porcine reproductive and respiratory syndrome virus (PRRSV): A mini review. Toxicol Environ Health Sci, 7, 241–250. doi:10.1007/s13530-015-0254-9.
   Google Scholar
• Kokila K, Priyadharshini SD, Sujatha V. (2013). Phytopharmacological properties of Albizia species: a review. Int J Pharm Pharmaceut Sci, 5(Supp 3), 70–73.
   Google Scholar
• Kristensen CS, Kvisgaard LK, Pawlowski M, et al. (2018). Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs. Vaccine, 36, 227–236. doi:10.1016/j.vaccine.2017.11.059.
   PubMed Web of Science ®Google Scholar
• Li GX, Shi N, Sqgw S, et al. (2012). Vaccination of mice with ORF5 plasmid DNA of PRRSV; enhanced effects by co-immunizing with porcine IL-15. Immunol Invest, 41, 231–248. doi:10.3109/08820139.2011.614306.
   PubMed Web of Science ®Google Scholar
• Li X, Galliher-Beckley A, Nietfeld JC, et al. (2013). MontanideTM Gel01 ST adjuvant enhances PRRS modified live vaccine efficacy by regulating porcine humoral and cellular immune responses. World J Vaccines, 3, 1–9. doi:10.4236/wjv.2013.31001.
   Google Scholar
• Lowe JE, Husmann R, Firkins LD, et al. (2005). Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herds. J Am Vet Med Assoc, 226, 1707–1711. doi:10.2460/javma.2005.226.1707.
   PubMed Web of Science ®Google Scholar
• Lunney JK, Fang Y, Ladinig A, et al. (2016). Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci, 4, 129–154. doi:10.1146/annurev-animal-022114-111025.
   PubMed Web of Science ®Google Scholar
• Lyoo KS, Choi JY, Hahn TW, et al. (2016). Effect of vaccination with a modified live porcine reproductive and respiratory syndrome virus vaccine on growth performance in fattening pigs under field conditions. J Vet Med Sci, 78, 1533–1536. doi:10.1292/jvms.16-0137.
   PubMed Web of Science ®Google Scholar
• Mair KH, Koinig H, Gerner W, et al. (2015). Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS® MLV. Vet Microbiol, 176, 352–357. doi:10.1016/j.vetmic.2015.02.001.
   PubMed Web of Science ®Google Scholar
• McKee AS, Munks MW, Marrack P. (2007). How do adjuvants work? Important considerations for new generation adjuvants. Immunity, 27, 687–690. doi:10.1016/j.immuni.2007.11.003.
   PubMed Web of Science ®Google Scholar
• Meier WA, Husmann RJ, Schnitzlein WM, et al. (2004). Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol, 102, 299–314. doi:10.1016/j.vetimm.2004.09.012.
   PubMed Web of Science ®Google Scholar
• Mokhtar H, Biffar L, Somavarapu S, et al. (2017). Evaluation of hydrophobic chitosan-based particulate formulations of porcine reproductive and respiratory syndrome virus vaccine candidate T cell antigens. Vet Microbiol, 209, 66–74. doi:10.1016/j.vetmic.2017.01.037.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Sad S. (1996). The expanding universe of T-cells subsets: th1, Th2 and more. Immunol Today, 17, 138–146. doi:10.1016/0167-5699(96)80606-2.
   PubMedGoogle Scholar
• Murtaugh MP, Genzow M. (2011). Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). Vaccine, 29, 8192–8204. doi:10.1016/j.vaccine.2011.09.013.
   PubMed Web of Science ®Google Scholar
• Oyston P, Robinso K. (2012). The current challenges for vaccine development. J Med Microbiol, 61, 889–894. doi:10.1099/jmm.0.039180-0.
   PubMed Web of Science ®Google Scholar
• Park C, Seo HW, Han K, et al. (2014). Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge. Vet Microbiol, 172, 432–442. doi:10.1016/j.vetmic.2014.05.030.
   PubMed Web of Science ®Google Scholar
• Renukaradhya GJ, Meng XJ, Calvert JG, et al. (2015a). Live porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine, 33, 4069–4080. doi:10.1016/j.vaccine.2015.06.092.
   PubMed Web of Science ®Google Scholar
• Renukaradhya GJ, Meng XJ, Calvert JG, et al. (2015b). Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction. Vaccine, 33, 3065–3072. doi:10.1016/j.vaccine.2015.04.102.
   PubMed Web of Science ®Google Scholar
• Schijns VE. (2001). Induction and direction of immune responses by vaccine adjuvants. Crit Rev Immunol, 21, 75–85. doi:10.1615/CritRevImmunol.v21.i1-3.50.
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Piñeyro P, Derscheid RJ, et al. (2017). Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs. Vet Immunol Immunopathol, 190, 18–25. doi:10.1016/j.vetimm.2017.07.003.
   PubMed Web of Science ®Google Scholar
• Sun HX, He SW, Shi MH. (2014). Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection. Int Immunopharmacol, 22, 346–355. doi:10.1016/j.intimp.2014.07.021.
   PubMed Web of Science ®Google Scholar
• Sun HX, Wang H, Xu HS, Ni Y. (2009). Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine, 27, 3984–3991. doi:10.1016/j.vaccine.2009.04.037.
   PubMed Web of Science ®Google Scholar
• Sun HX, Zhang J, Chen FY, et al. (2015). Activation of RAW264.7 macrophages by the polysaccharides from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym, 121, 388–402. doi:10.1016/j.carbpol.2014.12.023.
   PubMed Web of Science ®Google Scholar
• Sun HY, Workman A, Osorio FA, et al. (2018). Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus. Vaccine, 36, 66–73. doi: 10.1016/j.vaccine.2017.11.028.
   PubMed Web of Science ®Google Scholar
• Thakur A, Pedersen LE, Jungersen G. (2012). Immune markers and correlates of protection for vaccine induced immune responses. Vaccine, 30, 4907–4920. doi:10.1016/j.vaccine.2012.05.049.
   PubMed Web of Science ®Google Scholar
• Vu HLX, Pattnaik AK, Osorio FA. (2017). Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus. Vet Microbiol, 206, 29–34. doi:10.1016/j.vetmic.2016.09.014.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Liu Y, Wu YJ, et al. (2016). The potential adjuvanticity of quaternized chitosan hydrogel based microparticles for porcine reproductive and respiratory syndrome virus inactivated vaccine. Int Immunopharmacol, 39, 84–91. doi:10.1016/j.intimp.2016.07.012.
   PubMed Web of Science ®Google Scholar
• Wei DH, Qiao SY, Zhao YM. (2004). Advances in study on bark of Albizzia julibrissin. Chin J Chin Materia Med, 29, 619–624.
   Google Scholar
• Woodland DL. (2003). Cell-mediated immunity to respiratory virus infections. Curr Opin Immunol, 15, 430–435. doi:10.1016/S0952-7915(03)00067-0.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Batista L, Dee S, et al. (2004). The level of virus-specific T-Cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. J Virol, 78, 5923–5933. doi:10.1128/JVI.78.11.5923-5933.2004.
   PubMed Web of Science ®Google Scholar
• Zhong W, Roberts AD, Woodland DL. (2001). Antibody-dependent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. J Immunol, 167, 1379–1386. doi:10.4049/jimmunol.167.3.1379.
   PubMed Web of Science ®Google Scholar
• Zuckermann FA, Garcia EA, Luque ID, et al. (2007). Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol, 123, 69–85. doi:10.1016/j.vetmic.2007.02.009.
   PubMed Web of Science ®Google Scholar